These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33118182)

  • 1. Reproducibility analysis of multi-institutional paired expert annotations and radiomic features of the Ivy Glioblastoma Atlas Project (Ivy GAP) dataset.
    Pati S; Verma R; Akbari H; Bilello M; Hill VB; Sako C; Correa R; Beig N; Venet L; Thakur S; Serai P; Ha SM; Blake GD; Shinohara RT; Tiwari P; Bakas S
    Med Phys; 2020 Dec; 47(12):6039-6052. PubMed ID: 33118182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Habitat-derived Radiomic Features at Pretreatment MRI That Are Prognostic for Progression-free Survival in Glioblastoma Are Associated with Key Morphologic Attributes at Histopathologic Examination: A Feasibility Study.
    Verma R; Correa R; Hill VB; Statsevych V; Bera K; Beig N; Mahammedi A; Madabhushi A; Ahluwalia M; Tiwari P
    Radiol Artif Intell; 2020 Nov; 2(6):e190168. PubMed ID: 33330847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of tumor segmentation in glioblastoma: Impact on the robustness of MRI-radiomic features.
    Tixier F; Um H; Young RJ; Veeraraghavan H
    Med Phys; 2019 Aug; 46(8):3582-3591. PubMed ID: 31131906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.
    Bakas S; Sako C; Akbari H; Bilello M; Sotiras A; Shukla G; Rudie JD; Santamaría NF; Kazerooni AF; Pati S; Rathore S; Mamourian E; Ha SM; Parker W; Doshi J; Baid U; Bergman M; Binder ZA; Verma R; Lustig RA; Desai AS; Bagley SJ; Mourelatos Z; Morrissette J; Watt CD; Brem S; Wolf RL; Melhem ER; Nasrallah MP; Mohan S; O'Rourke DM; Davatzikos C
    Sci Data; 2022 Jul; 9(1):453. PubMed ID: 35906241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
    Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
    Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
    Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
    J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of image preprocessing on the scanner dependence of multi-parametric MRI radiomic features and covariate shift in multi-institutional glioblastoma datasets.
    Um H; Tixier F; Bermudez D; Deasy JO; Young RJ; Veeraraghavan H
    Phys Med Biol; 2019 Aug; 64(16):165011. PubMed ID: 31272093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma.
    Beig N; Bera K; Prasanna P; Antunes J; Correa R; Singh S; Saeed Bamashmos A; Ismail M; Braman N; Verma R; Hill VB; Statsevych V; Ahluwalia MS; Varadan V; Madabhushi A; Tiwari P
    Clin Cancer Res; 2020 Apr; 26(8):1866-1876. PubMed ID: 32079590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans in hepatocellular carcinoma patients: impact of tumor segmentation variability.
    Qiu Q; Duan J; Duan Z; Meng X; Ma C; Zhu J; Lu J; Liu T; Yin Y
    Quant Imaging Med Surg; 2019 Mar; 9(3):453-464. PubMed ID: 31032192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features.
    Bakas S; Akbari H; Sotiras A; Bilello M; Rozycki M; Kirby JS; Freymann JB; Farahani K; Davatzikos C
    Sci Data; 2017 Sep; 4():170117. PubMed ID: 28872634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Radiomic Features in Glioblastoma Multiforme: Impact of Semi-Automated Tumor Segmentation Software.
    Lee M; Woo B; Kuo MD; Jamshidi N; Kim JH
    Korean J Radiol; 2017; 18(3):498-509. PubMed ID: 28458602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions.
    Tunali I; Hall LO; Napel S; Cherezov D; Guvenis A; Gillies RJ; Schabath MB
    Med Phys; 2019 Nov; 46(11):5075-5085. PubMed ID: 31494946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable and Discriminatory Radiomic Features from the Tumor and Its Habitat Associated with Progression-Free Survival in Glioblastoma: A Multi-Institutional Study.
    Verma R; Hill VB; Statsevych V; Bera K; Correa R; Leo P; Ahluwalia M; Madabhushi A; Tiwari P
    AJNR Am J Neuroradiol; 2022 Aug; 43(8):1115-1123. PubMed ID: 36920774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RADIomic Spatial TexturAl Descriptor (RADISTAT): Quantifying Spatial Organization of Imaging Heterogeneity Associated With Tumor Response to Treatment.
    Antunes JT; Ismail M; Hossain I; Wang Z; Prasanna P; Madabhushi A; Tiwari P; Viswanath SE
    IEEE J Biomed Health Inform; 2022 Jun; 26(6):2627-2636. PubMed ID: 35085099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of image preprocessing methods on reproducibility of radiomic features in multimodal magnetic resonance imaging in glioblastoma.
    Moradmand H; Aghamiri SMR; Ghaderi R
    J Appl Clin Med Phys; 2020 Jan; 21(1):179-190. PubMed ID: 31880401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
    Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
    Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent Diffusion Coefficient as a Predictive Biomarker for Survival in Patients with Treatment-Naive Glioblastoma Using Quantitative Multiparametric Magnetic Resonance Profiling.
    Kim BS; Kim ST; Kim JH; Seol HJ; Nam DH; Shin HJ; Lee JI; Kong DS
    World Neurosurg; 2019 Feb; 122():e812-e820. PubMed ID: 30391622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.